For the Canadian cannabis group Tilray was a report on Tuesday.
Tilray wrote red numbers in the third quarter of the 2025 financial year. The EPS was – $ 0.87 after a year ago a 0 had been achieved at the win. The analyst estimates for the profit had been in advance at $ 0.03 so that underbot Tilray.
Booming cannabis shares: This is how you can invest in the cannabis stock index. (Advertisement)
Plus500: Please note the References5 To this advertising.
In the meantime, sales were $ 185.78 million in the reporting quarter after $ 188.34 million in the same period last year. Analysts had believed the company of $ 209.77 million in advance that Tilray did not achieve.
The Tilray share at the Nasdaq is at times 17.95 percent weaker at $ 0.4753.
Editor finance.net
By the way: Tilray (ex Aphria) and other US shares are even tradable at Finance.net Zero until 11 p.m. (without order fees, plus spreads). Open Depot now for free And receive a free stock as a gift.
Selected leverage products on Tilray (ex Aphria)
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the desired lever and we will show you suitable open-end products on Tilray (ex APHRIA)
The lever must be between 2 and 20
Advertising